加味导痰汤联合西药治疗痰热风动型帕金森病伴功能性便秘临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.35;R277.7

基金项目:

湖州市科学技术局公益性应用研究项目(2022GY08)


Clinical Study on Modified Daotan Decoction Combined with Western Medicine for Parkinson's Disease of Phlegm-Heat and Stirring Wind Type Complicated by Functional Constipation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察加味导痰汤联合西药治疗痰热风动型帕金森病(PD) 伴功能性便秘的临床疗效。方法:纳入2024年1月—2025年5月浙江中医药大学附属湖州中医院收治的80例痰热风动型PD伴功能性便秘患者作为研究对象,按随机数字表法分为对照组与治疗组各40例。2组均给予PD基础治疗,口服枸橼酸莫沙必利片治疗,治疗组联合加味导痰汤治疗,2组均治疗4周。治疗前后评估中医证候评分、PD自主神经症状量表(SCOPA-AUT) 评分、便秘患者生活质量自评量表(PAC-QOL) 评分,检测血清免疫球蛋白[免疫球蛋白A(IgA)、免疫球蛋白M(IgM)、免疫球蛋白G(IgG)]、T淋巴细胞亚群(CD3+、CD4+、CD8+) 及肠道菌群数量(乳杆菌、双歧杆菌、肠球菌、大肠埃希菌)。比较2组的临床疗效及治疗期间的不良反应发生率。结果:治疗4周后,治疗组总有效率高于对照组(P<0.05)。2组中医证候积分、SCOPA-AUT评分、PAC-QOL评分均较治疗前下降(P<0.05),治疗组3项评分均低于对照组(P<0.05)。治疗组IgA、IgG水平均较治疗前降低,IgM水平较治疗前升高,差异均有统计学意义(P<0.05)。治疗组IgA、IgG水平均低于对照组,IgM水平高于对照组,差异均有统计学意义(P<0.05)。治疗组CD3+、CD4+水平均较治疗前升高,CD8+水平较治疗前下降,差异均有统计学意义(P<0.05)。治疗组CD3+、CD4+水平均高于对照组,CD8+水平低于对照组,差异均有统计学意义(P<0.05)。2组乳杆菌、双歧杆菌数量均较治疗前增加,肠球菌、大肠埃希菌数量均较治疗前减少,差异均有统计学意义(P<0.05)。治疗组乳杆菌、双歧杆菌数量均多于对照组,肠球菌、大肠埃希菌数量均少于对照组,差异均有统计学意义(P<0.05)。用药期间,治疗组不良反应发生率低于对照组(P<0.05)。结论:采用加味导痰汤联合西药治疗痰热风动型PD伴功能性便秘可提高疗效,减轻患者的临床症状,改善自主神经功能,提升患者生活质量。其起效机制可能与调节机体免疫状态、纠正肠道菌群紊乱相关,且联合用药安全性良好、临床耐受性佳。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Daotan Decoction combined with western medicine for Parkinson′s disease (PD) of phlegm-heat and stirring wind type complicated by functional constipation. Methods: Eighty patients with PD of phlegm-heat and stirring wind type complicated by functional constipation admitted to Huzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University from January 2024 to May 2025 were included as the research subjects. They were divided into the control group and the treatment group according to the random number table method,with 40 patients in each group. Both groups received basic treatment for PD,including Mosapride Citrate Tablets. The treatment group was additionally treated with modified Daotan Decoction, and both groups were treated for four weeks. Before and after treatment,the traditional Chinese medicine syndrome scores,the Scale for Outcomes in Parkinson′s Disease-Autonomic( SCOPA-AUT) scores,and Patient Assessment of Constipation- Quality of Life (PAC-QOL) scores were evaluated, and serum immunoglobulin [immunoglobulin A (IgA), immunoglobulin M( IgM),immunoglobulin G( IgG)] levels,T lymphocyte subsets( CD3+,CD4+,CD8+) levels,and gut microbiota (Lactobacilli,Bifidobacteria,Enterococci,Escherichia coli) counts were detected. The clinical effects and incidence of adverse reactions during treatment were compared between the two groups. Results:After four weeks of treatment, the total effective rate in the treatment group was higher than that in the control group (P<0.05). The traditional Chinese medicine syndrome scores, SCOPA-AUT scores, and PAC-QOL scores in both groups were decreased when compared with those before treatment (P<0.05), and the above three scores in the treatment group were lower than those in the control group (P<0.05). The levels of IgA and IgG in the treatment group were reduced when compared with those before treatment, and the IgM level was increased when compared with that before treatment( P<0.05). The levels of IgA and IgG in the treatment group were lower than those in the control group,while the IgM level was higher than that in the control group,and the differences were statistically significant( P<0.05). The levels of CD3+ and CD4+ in the treatment group were increased when compared with those before treatment, and the CD8+ level was reduced when compared with that before treatment,differences being significant (P<0.05). The levels of CD3+ and CD4+ in the treatment group were higher than those in the control group,and the CD8+ level was lower than that in the control group, differences being significant (P<0.05). The count of Lactobacilli and Bifidobacteria in the two groups was elevated compared with that before treatment, and the count of Enterococci and Escherichia coli was reduced compared with that before treatment, differences being significant (P<0.05). The count of Lactobacilli and Bifidobacteria in the treatment group was higher than that in the control group (P<0.05),and the count of Enterococci and Escherichia coli was lower than that in the control group,differences being significant( P<0.05). During treatment, the incidence of adverse reactions in the treatment group was lower than that in the control group (P<0.05). Conclusion:The combination use of modified Daotan Decoction and western medicine can improve the curative effect on PD of phlegm-heat and stirring wind type complicated by functional constipation, which can alleviate the clinical symptoms,improve the autonomic nervous system function,and enhance the quality of life of patients. Its mechanism may be related to the regulation of the systemic immune status, and the correction of intestinal microbiota disorders, with good safety and clinical tolerance.

    参考文献
    相似文献
    引证文献
引用本文

吴秋艳,艾宗耀,肖梅红,周振婷,丁伟军.加味导痰汤联合西药治疗痰热风动型帕金森病伴功能性便秘临床研究[J].新中医,2026,58(18):12-19

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-09-29
  • 出版日期:
文章二维码